We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Medical

C-Major

Status: Funded

Nov 2nd 2020 - Dec 2nd 2020

C-Major is a medical technology company. It asserts that over 2 million people suffer a Needle Stick Injury (NSI) every year and are at risk of contracting blood-borne viruses such as Hepatitis and HIV. It aspires to resolve this crisis by bringing to market its patented medical device, Controlled Helical Retraction Device, to prevent NSIs. The company argues that the device contains a ‘Helical Track’ mechanism for controlled acceleration of the needle during retraction as well as a ‘Sealed Port’ to minimise any blood splatter. C-Major endeavours to disrupt the $5.5 billion safety syringe market with its product. It is backed by the UK 'Innovation Seed' fund. C-Major will use the investment to complete the final design of its product for manufacture and assembly ahead of a Series A funding round in 2021.

read more read less

C-Major Rating Review

Pitch rating powered by CROWDRATING

Rated on 10/11/2020

Pitch Rated

53%

Insufficient Data

Management

79%

Product

81%

Investment

UNRATED*

* Section unrated owing to insufficient or incomplete information available at the time of rating.

Log in to view amount pledged

    Log in to view target

    £2,208,129
    pre-money valuation

    5.56%
    equity available

    390
    investors

    £543
    pledge per investor

    05563638
    company number

    Active
    company status

    14/09/2005
    incorporated 19 years

    £6.54
    share price

    Previous Funding rounds
    02 May 24 Crowdcube £211,595 / 163% 53.33%
    Officers

What the ratings mean

  • 49% and under
    We suggest potential investors carry out further study of their own
    50-64%
    Room for improvement
    65-79%
    Worth considering
    80%+
    Gold rating, our highest rating

RISK WARNING - The ratings are based on the information provided in the fund raiser’s pitch deck, business plans and financial forecasts which have appeared on a FCA regulated crowdfunding site. Where possible we validate the business plan to public sources such as LinkedIn, Companies House, Credit Agencies and internet searches. We cannot guarantee the information is correct. The ratings report takes no account of the investors/ individual circumstances. Do your own due diligence and get professional advice before investing. Your capital is at risk when investing in private companies.

Login to view the full report

Management 79%

Skills 91%
C-Major Medical was founded by three colleagues who realised that existing medical products were not bringing about the desired reduction in Needle Stick Injuries (NSIs). The management team includes skilled professionals with expertise in their functional areas -manufacturing, product development, strategic marketing and project management. The CEO is skilled in leadership, marketing, commercial market access, market development, product development, niche market development and numerous pricing and reimbursement roles. The Chairman has a track record in early-stage and high-growth medical diagnostics, life science and service companies looking for new and exiting NED or Chairman roles. The COO/Projects Director has expertise in international divisional sales & marketing, strategic marketing and planning. His role is to introduce products into the market by contacting and collaborating with key influencers within the industry who are aware of the continuing problem of Needle Stick Injuries. The CTO is specialising in product development, world-class manufacturing, integrating lean, six-sigma and TPM. He is the winner of Britain’s Best Factory Award for World Class Manufacturing in 2006. The CCO is skilled in business strategy, building contracts and project management. The COO is also running the finances of the company, including interfacing with government agencies who support small startup companies. It was noted that their accounting and finance roles had been outsourced and they are backed by chartered accountants and lawyers with experience in startup businesses offering a full range of accountancy, taxation, business consultancy and audit services.

0 comments

Log in to comment


Funding progress

Log in to view funding progress.


Log in to view amount pledged

    Log in to view target

    £2,208,129
    pre-money valuation

    5.56%
    equity available

    390
    investors

    £543
    pledge per investor

    05563638
    company number

    Active
    company status

    14/09/2005
    incorporated 19 years

    £6.54
    share price

    Previous Funding rounds
    03 May 24 Crowdcube £211,595 / 163% 53.33%
    Officers
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph